Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer
Abstract Background Kidney cancer is one of the most common cancers in the world. It is necessary to clarify its underlying mechanism and find its prognostic biomarkers. Current studies showed that SHMT2 may be participated in several kinds of cancer. Methods Our studies investigated the expression...
Main Authors: | Huan Wang, Tie Chong, Bo-Yong Li, Xiao-San Chen, Wen-Bo Zhen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Biological Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40659-020-00314-2 |
Similar Items
-
SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer
by: Meihua Jin, et al.
Published: (2021-06-01) -
SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma
by: Yongli Situ, et al.
Published: (2023-09-01) -
SHMT2 Promotes Invasion and Migration of Breast Cancer Cells Through Binding to and Up-regulating HAX1
by: CHEN Qianzhi, et al.
Published: (2023-09-01) -
Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer
by: Peng Zhang, et al.
Published: (2021-06-01) -
Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer
by: Jun Li, et al.
Published: (2023-04-01)